Clinical Trial Update: Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer [Phase 1]

View source ↗

Summary

Phase 1 pilot trial evaluating rutin in combination with tislelizumab and gemcitabine/cisplatin as neoadjuvant therapy for platinum-refractory muscle-invasive b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Rutin (rutin)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: First Affiliated Hospital of Chongqing Medical University | Conditions: Muscle Invasive Bladder Cancer | Phase 1 | Status: RECRUITING